Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederbiopharmadive.com
BioPharma Dive - Latest News
Get the latest updates from BioPharma Dive - Latest News directly as they happen.
Follow now 155 followers
Latest posts
Last updated about 21 hours ago
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene
about 21 hours ago
The clearance of Zenbexus is the first for a group of protein-degrading...
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
about 24 hours ago
The FDA is “willing to review” an updated submission for Capricor’s Duchenne...
Biotech initiatives pick up as more regions race to become hubs
1 day ago
New government funding from Pennsylvania to Kansas City is strengthening biotech hubs...
New Taiho, Cullian data heats up lung cancer drug battle
2 days ago
The findings position their drug, zipalertinib, as a threat to multiple approved...
PTC takes a chance on Sangamo’s Fabry disease gene therapy
2 days ago
Wall Street analysts view the deal as a risky, high-reward bet on...
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
3 days ago
Ahead of an approval filing, the drugmaker is amping up a fight...
Psychedelics developer Definium scores more positive data for LSD pill
3 days ago
Results from a late-stage study focused on generalized anxiety disorder were a...
Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines
3 days ago
Some analysts believe Silence’s polycythemia vera drug could be superior to a...
Boulevard starts up with $65M to pursue targeted autoimmune drugs
3 days ago
Co-founded by pioneering researcher Georg Schett and ex-Sanofi CSO Frank Nestle, the...
Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs
4 days ago
Ying Huang is now running K2 Therapeutics, which has licensed multiple prospects...
Trump signs order seeking to upend childhood vaccine schedule
4 days ago
The executive order — which wasn’t accompanied by any new scientific evidence...
Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
4 days ago
Infinimmune, a California startup, is developing treatments it claims might last longer...